Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes—“Immunological Dose Painting”

The combination of immune checkpoint inhibitors and definitive radiotherapy is investigated for the multimodal treatment of cisplatin non-eligible locally advanced head and neck cancers (HNC). In the case of recurrent and metastatic HNC, immunotherapy has shown benefit over the EXTREME protocol, bei...

Descripción completa

Detalles Bibliográficos
Autores principales: Mireştean, Camil Ciprian, Crişan, Anda, Buzea, Călin, Iancu, Roxana Irina, Iancu, DragoşPetru Teodor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824056/
https://www.ncbi.nlm.nih.gov/pubmed/33374739
http://dx.doi.org/10.3390/medicina57010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824056/
https://www.ncbi.nlm.nih.gov/pubmed/33374739
http://dx.doi.org/10.3390/medicina57010006

Ejemplares similares